BARCLAYS PLC - LONGBOARD PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of LONGBOARD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$16
-30.4%
2,787
-10.8%
0.00%
Q2 2023$233,1240.00%
Other shareholders
LONGBOARD PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,353,141$13,083,4640.76%
Integral Health Asset Management, LLC 760,000$4,225,6000.58%
Prosight Management, LP 321,154$1,785,6160.57%
Parkman Healthcare Partners LLC 355,957$1,979,1210.36%
Ikarian Capital, LLC 514,101$2,858,4010.34%
FARALLON CAPITAL MANAGEMENT LLC 1,560,500$8,676,3800.04%
Polar Capital Holdings Plc 1,000,000$5,560,0000.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 262,265$1,458,1930.04%
BOOTHBAY FUND MANAGEMENT, LLC 112,614$626,1340.02%
Point72 Asset Management, L.P. 825,000$4,587,0000.01%
View complete list of LONGBOARD PHARMACEUTICALS IN shareholders